Related Experiment Video
Updated: Jun 8, 2026
06:12
Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
Published on: January 27, 2022
Progress and prospects: stem cells and neurological diseases.
S Gögel1, M Gubernator, S L Minger
1Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College London, London, UK. stefanie.gogel@kcl.ac.uk
Gene Therapy
|October 1, 2010
Summary
Stem cell transplantation offers a promising therapeutic approach for neurodegenerative diseases like Parkinson's and Huntington's disease, and brain injuries such as stroke, addressing the central nervous system's limited regeneration capacity.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- The central nervous system (CNS) exhibits limited intrinsic regenerative capacity, hindering recovery from neurodegenerative diseases (e.g., Parkinson's disease, Alzheimer's disease, Huntington's disease) and acute injuries (e.g., stroke, spinal cord injury).
- While endogenous stem cells exist in the adult brain, their contribution to functional recovery is minimal.
- Cellular transplantation strategies are being explored to replace lost neuronal populations and restore function.
Purpose of the Study:
- To review current strategies for replacing lost cellular populations in the CNS.
- To focus on therapeutic applications for Huntington's disease, Parkinson's disease, stroke, and other traumatic brain injuries.
- To discuss the technical and biological challenges inherent in CNS cell transplantation.
Main Methods:
- Review of existing literature on stem cell transplantation for neurological disorders.
- Analysis of induced pluripotent stem cells (iPSCs) as a potential source for transplantable cells.
- Discussion of challenges in cell survival, integration, and functional restoration within the CNS.
Main Results:
- Stem cell transplantation is a key strategy for addressing CNS damage.
- Induced pluripotent stem cells offer a novel and potentially superior source for therapeutic cell generation.
- Significant technical and biological hurdles remain for successful CNS cell transplantation.
Conclusions:
- Cellular replacement therapies hold promise for treating neurodegenerative conditions and brain injuries.
- Advancements in stem cell technology, particularly iPSCs, may overcome limitations of current approaches.
- Further research is crucial to address the complexities of CNS repair through transplantation.
More Related Videos
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
09:37A cGMP-applicable Expansion Method for Aggregates of Human Neural Stem and Progenitor Cells Derived From Pluripotent Stem Cells or Fetal Brain Tissue
Published on: June 15, 2014
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...